Biosimilars Market 2022-2028
June 11, 2022 ⚊ 1 Min read ⚊ Views 105 ⚊ BUSINESS
Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Any differences are carefully evaluated by manufacturers and reviewed by the FDA to ensure the biosimilar meets the Agency’s appropriately high approval standards.
Tags: Biosimilars Market
